Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner von Myöhänen, TT, Tenorio‐Laranga, J, Jokinen, B, Vázquez‐Sánchez, R, Moreno‐Baylach, MJ, García‐Horsman, JA, Männistö, PT

Volltext

Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy von Cui, H., Norrbacka, S., Myöhänen, T.T.

Volltext

New tricks of prolyl oligopeptidase inhibitors – A common drug therapy for several neurodegenerative diseases von Svarcbahs, Reinis, Julku, Ulrika, Kilpeläinen, Tommi, Kyyrö, Mirva, Jäntti, Maria, Myöhänen, Timo T.

Volltext

Prolyl oligopeptidase inhibition reduces oxidative stress via reducing NADPH oxidase activity by activating protein phosphatase 2A von Eteläinen, T., Kulmala, V., Svarcbahs, R., Jäntti, M., Myöhänen, T.T.

Volltext

A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease von Myöhänen, TT, Hannula, MJ, Van Elzen, R, Gerard, M, Van Der Veken, P, García‐Horsman, JA, Baekelandt, V, Männistö, PT, Lambeir, AM

Volltext

Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric S... von Svarcbahs, Reinis, Julku, Ulrika H, Myöhänen, Timo T

Volltext

Deletion or inhibition of prolyl oligopeptidase blocks lithium‐induced phosphorylation of GSK3b and Akt by activation of protein phosphatase 2A von Myöhänen, Timo T., Mertens, Freke, Norrbacka, Susanna, Cui, Hengjing

Volltext

Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo von Svarcbahs, Reinis, Julku, Ulrika H., Norrbacka, Susanna, Myöhänen, Timo T.

Volltext

The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse von Savolainen, Mari H, Richie, Christopher T, Harvey, Brandon K, Männistö, Pekka T, Maguire-Zeiss, Kathleen A, Myöhänen, Timo T

Volltext

Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A von Svarcbahs, Reinis, Jäntti, Maria, Kilpeläinen, Tommi, Julku, Ulrika H., Urvas, Lauri, Kivioja, Saara, Norrbacka, Susanna, Myöhänen, Timo T.

Volltext

Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases von Hannula, M.J, Myöhänen, T.T, Tenorio-Laranga, J, Männistö, P.T, Garcia-Horsman, J.A

Volltext

Behavioural and dopaminergic changes in double mutated human A30PA53T alpha-synuclein transgenic mouse model of Parkinson´s disease von Kilpeläinen, Tommi, Julku, Ulrika H., Svarcbahs, Reinis, Myöhänen, Timo T.

Volltext

Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease von Norrbacka, Susanna, Lindholm, Dan, Myöhänen, Timo T.

Volltext

5‑Aminothiazoles Reveal a New Ligand-Binding Site on Prolyl Oligopeptidase Which is Important for Modulation of Its Protein–Protein Interaction-Derived Functions von Pätsi, Henri T., Kilpeläinen, Tommi P., Jumppanen, Mikael, Uhari-Väänänen, Johanna, Wielendaele, Pieter Van, De Lorenzo, Francesca, Cui, Hengjing, Auno, Samuli, Saharinen, Janne, Seppälä, Erin, Sipari, Nina, Savinainen, Juha, De Meester, Ingrid, Lambeir, Anne-Marie, Lahtela-Kakkonen, Maija, Myöhänen, Timo T., Wallén, Erik A. A.

Volltext

Prolyl Oligopeptidase Enhances α-Synuclein Dimerization via Direct Protein-Protein Interaction von Savolainen, Mari H., Yan, Xu, Myöhänen, Timo T., Huttunen, Henri J.

Volltext

Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α‑Synuclein Mouse Models of Parkinson’s Disease von Kilpeläinen, Tommi P., Pätsi, Henri T., Svarcbahs, Reinis, Julku, Ulrika H., Eteläinen, Tony S., Cui, Hengjing, Auno, Samuli, Sipari, Nina, Norrbacka, Susanna, Leino, Teppo O., Jäntti, Maria, Myöhänen, Timo T., Wallén, Erik A. A.

Volltext

Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson’s disease in young and adult mouse von Savolainen, Mari H., Albert, Katrina, Airavaara, Mikko, Myöhänen, Timo T.

Volltext

Corrigendum to “Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases”... von Hannula, M.J, Myöhänen, T.T, Tenorio-laranga, J, Männistö, P.T, Garcia-horsman, J.A

Volltext

Nigrostriatal 6-hydroxydopamine lesions increase alpha-synuclein levels and permeability in rat colon von Cui, Hengjing, Elford, Joshua D., Alitalo, Okko, Perez-Pardo, Paula, Tampio, Janne, Huttunen, Kristiina M., Kraneveld, Aletta, Forsberg, Markus M., Myöhänen, Timo T., Jalkanen, Aaro J.

Volltext

Prolyl oligopeptidase inhibition attenuates the toxicity of a proteasomal inhibitor, lactacystin, in the alpha-synuclein overexpressing cell culture von Myöhänen, Timo T., Norrbacka, Susanna, Savolainen, Mari H.

Volltext